Andere Sprachen Ocugen, Inc.

Aktien

A2PSZH

US67577C1053

OCGN

Realtime-Estimate Cboe BZX Andere Börsenplätze 18:26:53 05.06.2024			% 5 Tage	% 1. Jan.
1,835 ^USD	+2,51 %		+12,27 %	+218,26 %

31.05.	Sektor-Update: Aktien des Gesundheitswesens legen am Freitagnachmittag zu	MT
31.05.	Ocugen erhält Empfehlung für Dosis-Eskalation in Studie zur Augenkrankheit; Aktien steigen an	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

FINAL DEADLINE NEXT WEEK: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses In Excess of $250,000 to Contact the Firm	04.06.
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit	04.06.
OCGN DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm - OCGN	04.06.
Sector Update: Health Care Stocks Advance Friday Afternoon	31.05.
Ocugen Gets Recommendation For Dose Escalation in Eye Disease Trial; Shares Climb	31.05.
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen	31.05.
Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy	31.05.
Ocugen, Inc. Announces Positive Outcome of the Data and Safety Monitoring Board Review for its Phase 1/2 ArMaDa Clinical Trial for OCU410	31.05.
Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. - OCGN	30.05.
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm - OCGN	30.05.
OCUGEN SET TO JOIN RUSSELL 3000 INDEX EFFECTIVE JUNE 28, 2024	29.05.
Ocugen to Present at BIO International Convention 2024	29.05.
Ramesh Kumar Announces Not to Stand for Re-Election to the Board of Ocugen, Inc	28.05.
Ocugen Set to Join Russell 3000® Index Effective June 28, 2024	28.05.
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors	27.05.
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN	24.05.
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses In Excess of $250,000 to Contact the Firm	24.05.
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit	24.05.
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen	24.05.
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit	23.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ocugen, Inc.

Aktien

A2PSZH

US67577C1053

OCGN

Andere Sprachen

Filter